ACCD Stock Summary and Trading Ideas (Accolade | NASDAQ:ACCD)

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Accolade trades on the NASDAQ stock market under the symbol ACCD.

As of April 19, 2024, ACCD stock price declined to $9.13 with 815,233 million shares trading.

ACCD has a beta of 3.05, meaning it tends to be more sensitive to market movements. ACCD has a correlation of 0.24 to the broad based SPY ETF.

ACCD has a market cap of $706.73 million. This is considered a Small Cap stock.

Last quarter Accolade reported $99 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.16.

In the last 3 years, ACCD stock traded as high as $55.47 and as low as $4.61.

The top ETF exchange traded funds that ACCD belongs to (by Net Assets): ARKG, VTI, IWM, VXF, VB.

ACCD has underperformed the market in the last year with a return of -38.1%, while the SPY ETF gained +21.2%. In the last 3 month period, ACCD fell short of the market, returning -23.1%, while SPY returned +4.3%. However, in the most recent 2 weeks ACCD has outperformed the stock market by returning -1.3%, while SPY returned -3.5%.

ACCD support price is $8.85 and resistance is $9.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACCD stock will trade within this expected range on the day.